Unlike general ALCOA+ guidelines (Attributable, Legible, Contemporaneous, Original, Accurate, plus Complete, Consistent, Enduring, Available), TR 80 addresses the operational realities of a lab. It acknowledges that labs face unique challenges:
PDA Technical Report 80 is a comprehensive document that provides guidance on the design, testing, and validation of sterility assurance and sterility testing for parenteral and ophthalmic drug products. The report was first published in 2016 and has since become a widely accepted and referenced document in the pharmaceutical industry. pda technical report 80
– Many pharmaceutical companies and CROs hold a PDA membership and may have a site license. – Many pharmaceutical companies and CROs hold a
In the pharmaceutical and biotech industries, data is not merely a byproduct of testing; it is the foundation of patient safety and product quality. Over the last decade, regulatory bodies such as the FDA, MHRA, and WHO have shifted their inspection focus from merely checking final results to scrutinizing the integrity of the data lifecycle. regulatory bodies such as the FDA